<VariationArchive VariationID="190224" VariationName="NM_025243.4(SLC19A3):c.74dup (p.Ser26fs)" VariationType="Duplication" Accession="VCV000190224" Version="14" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-03-11" DateCreated="2015-05-09" MostRecentSubmission="2024-03-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="188047" VariationID="190224">
      <GeneList>
        <Gene Symbol="SLC19A3" FullName="solute carrier family 19 member 3" GeneID="80704" HGNC_ID="HGNC:16266" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q36.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="227683763" stop="227718028" display_start="227683763" display_stop="227718028" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="228549925" stop="228582744" display_start="228549925" display_stop="228582744" Strand="-" />
          </Location>
          <OMIM>606152</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_025243.4(SLC19A3):c.74dup (p.Ser26fs)</Name>
      <CanonicalSPDI>NC_000002.12:227702244:AAAAAA:AAAAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q36.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="227702244" stop="227702245" display_start="227702244" display_stop="227702245" variantLength="1" positionVCF="227702244" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="228566960" stop="228566961" display_start="228566960" display_stop="228566961" variantLength="1" positionVCF="228566960" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
      </Location>
      <ProteinChange>S26fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.228566966dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.228566966dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.227702250dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.227702250dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016359.1" sequenceAccession="NG_016359" sequenceVersion="1" change="g.20785dup">
            <Expression>NG_016359.1:g.20785dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_025243.4" sequenceAccession="NM_025243" sequenceVersion="4" change="c.74dup" MANESelect="true">
            <Expression>NM_025243.4:c.74dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_079519.1" sequenceAccession="NP_079519" sequenceVersion="1" change="p.Ser26fs">
            <Expression>NP_079519.1:p.Ser26fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_025243.3" sequenceAccession="NM_025243" sequenceVersion="3" change="c.74dupT">
            <Expression>NM_025243.3:c.74dupT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA274763" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="606152.0005" DB="OMIM" />
        <XRef Type="rs" ID="786205213" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_025243.4(SLC19A3):c.74dup (p.Ser26fs) AND Biotin-responsive basal ganglia disease" Accession="RCV000170443" Version="12">
        <ClassifiedConditionList TraitSetID="1254">
          <ClassifiedCondition DB="MedGen" ID="C1843807">Biotin-responsive basal ganglia disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-11-22" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_025243.4(SLC19A3):c.74dup (p.Ser26fs) AND not provided" Accession="RCV000367514" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-12-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-22" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2015-05-09" MostRecentSubmission="2024-03-10">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20065143</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23423671</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23482991</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27290639</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27896110</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1254" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="585" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Biotin-thiamine-responsive basal ganglia disease</ElementValue>
                <XRef ID="Basal+Ganglia+Disease%2C+Biotin-Responsive/756" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Biotin-responsive basal ganglia disease</ElementValue>
                <XRef ID="MONDO:0011841" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thiamine Transporter-2 Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">thiamine-responsive encephalopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thiamine metabolism dysfunction syndrome type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- AND THIAMINE-RESPONSIVE TYPE)</ElementValue>
                <XRef Type="MIM" ID="607483" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">THMD2</ElementValue>
                <XRef Type="MIM" ID="607483" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BBGD</ElementValue>
                <XRef Type="MIM" ID="607483" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">BBTGD</ElementValue>
                <XRef Type="MIM" ID="607483" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10237" />
                <XRef ID="10237" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Biotin-thiamine-responsive basal ganglia disease (BTBGD) may present in childhood, early infancy, or adulthood. The classic presentation of BTBGD occurs in childhood (age 3-10 years) and is characterized by recurrent subacute encephalopathy manifest as confusion, seizures, ataxia, dystonia, supranuclear facial palsy, external ophthalmoplegia, and/or dysphagia which, if left untreated, can eventually lead to coma and even death. Dystonia and cogwheel rigidity are nearly always present; hyperreflexia, ankle clonus, and Babinski responses are common. Hemiparesis or quadriparesis may be seen. Episodes are often triggered by febrile illness or mild trauma or stress. Simple partial or generalized seizures are easily controlled with anti-seizure medication. An early-infantile Leigh-like syndrome / atypical infantile spasms presentation occurs in the first three months of life with poor feeding, vomiting, acute encephalopathy, and severe lactic acidosis. An adult-onset Wernicke-like encephalopathy presentation is characterized by acute onset of status epilepticus, ataxia, nystagmus, diplopia, and ophthalmoplegia in the second decade of life. Prompt administration of biotin and thiamine early in the disease course results in partial or complete improvement within days in the childhood and adult presentations, but most with the infantile presentation have had poor outcome even after supplementation with biotin and thiamine.</Attribute>
                <XRef ID="NBK169615" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24260777</ID>
                <ID Source="BookShelf">NBK169615</ID>
              </Citation>
              <XRef ID="199348" DB="Orphanet" />
              <XRef ID="65284" DB="Orphanet" />
              <XRef ID="C1843807" DB="MedGen" />
              <XRef ID="MONDO:0011841" DB="MONDO" />
              <XRef Type="MIM" ID="607483" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1946476" SubmissionDate="2019-03-14" DateLastUpdated="2019-09-21" DateCreated="2019-09-21">
        <ClinVarSubmissionID localKey="NC_000002.11:g.228566966dupA|OMIM:607483" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000992833" DateUpdated="2019-09-21" DateCreated="2019-09-21" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-12-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20065143</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27290639</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC19A3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.228566966dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607483" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5321481</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="25005" SubmissionDate="2017-12-14" DateLastUpdated="2024-03-10" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606152.0005_BIOTIN-THIAMINE-RESPONSIVE BASAL GANGLIA DISEASE" title="SLC19A3, 1-BP DUP, 74T_BIOTIN-THIAMINE-RESPONSIVE BASAL GANGLIA DISEASE" />
        <ClinVarAccession Accession="SCV000025005" DateUpdated="2024-03-10" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2010-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Portuguese brother and sister with biotin-thiamine-responsive basal ganglia disease (BTBGD; 607483) Debs et al. (2010) identified compound heterozygosity for 2 mutations in the SLC19A3 gene: a 1-bp duplication (74dupT) in exon 2, resulting in a frameshift and premature termination, and an A-to-G transition in intron 3 (980-14A-G; 606152.0006), resulting in the skipping of exon 4 and an aberrantly spliced transcript degraded by nonsense-mediated mRNA decay. Each unaffected parent was heterozygous for 1 of the mutations. The brother was treated with high-dose biotin, which resulted in improvement of clinical features and disappearance of signal abnormalities on follow-up MRI. The sister was treated with high-dose biotin after worsening of her epilepsy, but she did not show improvement until thiamine was added.</Attribute>
              <Citation>
                <ID Source="PubMed">20065143</ID>
              </Citation>
              <XRef DB="OMIM" ID="607483" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC19A3" />
          </GeneList>
          <Name>SLC19A3, 1-BP DUP, 74T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 74T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606152.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">BIOTIN-THIAMINE-RESPONSIVE BASAL GANGLIA DISEASE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="405119" SubmissionDate="2015-04-20" DateLastUpdated="2015-05-09" DateCreated="2015-05-09">
        <ClinVarSubmissionID localKey="NC_000002.11:g.228566961dupA|OMIM:607483" />
        <ClinVarAccession Accession="SCV000222881" DateUpdated="2015-05-09" DateCreated="2015-05-09" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-12-23">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20065143</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC19A3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.228566961dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Basal ganglia disease, biotin-responsive</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="607483" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_004</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="643287" SubmissionDate="2022-12-14" DateLastUpdated="2022-12-17" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="GDXSV:252441" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000329937" DateUpdated="2022-12-17" DateCreated="2016-12-06" Type="SCV" Version="7" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26975589, 23469184, 27621386, 27290639, 27896110, 31589614, 31216405, 34631424, 20065143, 24957181)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC19A3" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:747113</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025243.3:c.74dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_150_20221214054204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3115820" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="3585064|MedGen:C1843807" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001590149" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23423671</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23482991</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20065143</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27896110</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ser26Leufs*19) in the SLC19A3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC19A3 are known to be pathogenic (PMID: 23423671, 23482991). This variant is present in population databases (rs786205213, gnomAD 0.002%). This premature translational stop signal has been observed in individuals with autosomal recessive biotin-responsive basal ganglia disease (PMID: 20065143, 27896110). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 190224). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC19A3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.228566960_228566961insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1843807" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="25005" TraitType="Disease" MappingType="Name" MappingValue="BIOTIN-THIAMINE-RESPONSIVE BASAL GANGLIA DISEASE" MappingRef="Preferred">
        <MedGen CUI="C1843807" Name="Biotin-responsive basal ganglia disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="643287" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1946476" TraitType="Disease" MappingType="XRef" MappingValue="607483" MappingRef="OMIM">
        <MedGen CUI="C1843807" Name="Biotin-responsive basal ganglia disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3115820" TraitType="Disease" MappingType="XRef" MappingValue="C1843807" MappingRef="MedGen">
        <MedGen CUI="C1843807" Name="Biotin-responsive basal ganglia disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="405119" TraitType="Disease" MappingType="Name" MappingValue="Basal ganglia disease, biotin-responsive" MappingRef="Preferred">
        <MedGen CUI="C1843807" Name="Biotin-responsive basal ganglia disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

